Precision oncology & personalized healthcare

The way people are being treated and diseases are being prevented is changing…for the good. For years, patients diagnosed with a disease often received the same treatment. And for some people, that treatment worked. However, for other patient populations it did not at all work – or only marginally or with serious side effects. This meant that, on average, only 50% of patients benefited from their treatment. This is changing with mapping of the genome, new analytical methods, and new scientific and technological advances. We are rapidly moving towards individualized treatments and disease interventions that will change how we care for people around the world.

Both researchers and physicians are expected to produce, integrate, and increasingly use large data sets on patients, diseases, and treatments. By mining this data, they will be able to gain new insights into what works and what doesn’t work for patient sub-populations. They will be able to better develop, match, and continuously optimize treatment for patients.

New science, more choices, and changing economics are redefining the healthcare landscape. We have conducted research to understand how oncology companies are responding to these trends.